Further, to test the impact of FLRT3-UNC5B pathway/blockade in a more physiologically relevant setting, we activated PBMCs from three different donors in mixed lymphocyte reaction (MLR) assay in the presence of SKOV3 and A549 cancer cell lines, which naturally express FLRT3. The gene discussed is UNC5B; the disease is cancer.